LADENBURG THALMANN FINANCIAL SERVICES INC. - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 24 filers reported holding TRILLIUM THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$4,000
+300.0%
3,5000.0%0.00%
Q3 2019$1,0000.0%3,5000.0%0.00%
Q2 2019$1,000
-50.0%
3,5000.0%0.00%
Q1 2019$2,000
-66.7%
3,5000.0%0.00%
Q4 2018$6,000
-70.0%
3,5000.0%0.00%
Q3 2018$20,000
-20.0%
3,5000.0%0.00%
Q2 2018$25,0000.0%3,5000.0%0.00%
Q1 2018$25,0000.0%3,5000.0%0.00%
Q4 2017$25,000
+2400.0%
3,500
+3400.0%
0.00%
Q3 2015$1,000
-50.0%
1000.0%0.00%
Q2 2015$2,0001000.00%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
NEA Management Company, LLC 2,100,000$646,0000.05%
Matrix Capital Management Company, LP 2,288,560$704,0000.02%
Tekla Capital Management LLC 446,099$137,0000.01%
Realta Investment Advisors 26,000$7,0000.00%
Virtu Financial LLC 34,991$11,0000.00%
Baker Brothers Advisors 505,262$155,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,044$6,0000.00%
MORGAN STANLEY 1,160,098$356,0000.00%
BANK OF MONTREAL /CAN/ 18,333$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 102,725$31,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders